Advertisement

Topics

Forest Laboratories, Inc. Company Profile

19:29 EDT 19th July 2018 | BioPortfolio

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people’s lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest’s current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY. To learn more about Forest Laboratories, visit www.frx.com.


News Articles [392 Associated News Articles listed on BioPortfolio]

Forest Blow, PTV News: Apr 08, 2010

FDA panel says no to Forest Laboratories' lung drug Daxas

Forest City Seats New Independent Directors

"We are thrilled to welcome our new independent directors to the Forest CityBoard," said David LaRue, President and Chief Executive Officer of Forest Read more...

Forest City Further Extends Nomination Window for 2018 Annual Meeting of Stockholders to ...

About Forest City Forest City Realty Trust, Inc. is an NYSE-listed national real estate company with $8.1 billionin consolidated assets. The Company is principally Read more...

Wake Forest researchers create advanced brain organoid to model strokes, screen drugs

(Wake Forest Baptist Medical Center) Wake Forest Institute for Regenerative Medicine scientists have developed a 3D brain organoid that could have potential applications in drug discovery and disease ...

Joint paper identifies one of Mesoamerica's last intact forest blocks

(Wildlife Conservation Society) The Wildlife Conservation Society (WCS) and Yale University have created a plan to preserve one of the last intact forest strongholds for the jaguar and other iconic sp...

Forest conservation can have greater ecological impacts by allowing sustainable harvesting

(University of Missouri-Columbia) New research at the University of Missouri has found that forest owners at greater risk of illegally cutting trees from their forests prefer to participate in conserv...

STAT Plus: U.S. attorney urged to re-open an investigation into an Allergan unit for alleged fraud

Documents indicate Forest Laboratories management obscured crucial information demonstrating the Celexa antidepressant was not effective in children.

Heterotrophic cultivation of Auxenochlorella protothecoides using forest biomass as a feedstock for sustainable biodiesel production

The aim of this work was to establish a process for the heterotrophic growth of green microalgae using forest biomass hydrolysates. To provide a carbon source for the growth of the green microalgae, t...

PubMed Articles [545 Associated PubMed Articles listed on BioPortfolio]

Losing sight of the Forest for the trees: Why clinical laboratories need to perform their own interference studies.

Dominant forest tree mycorrhizal type mediates understory plant invasions.

Forest mycorrhizal type mediates nutrient dynamics, which in turn can influence forest community structure and processes. Using forest inventory data, we explored how dominant forest tree mycorrhizal ...

Moisture content estimation of forest litter based on remote sensing data.

As a fine fuel, forest litter plays an important role in fire danger rating systems, so forest litter moisture data are necessary and meaningful for fire risk management and prevention. An optical rem...

An eco-efficient and economical optimum evaluation technique for the forest road networks: the case of the mountainous forest of Metsovo, Greece.

The sustainable forest management can be achieved only through environmentally sound and economically efficient and feasible forest road networks and transportation systems that can potentially improv...

Global patterns of tropical forest fragmentation.

Remote sensing enables the quantification of tropical deforestation with high spatial resolution. This in-depth mapping has led to substantial advances in the analysis of continent-wide fragmentation ...

Clinical Trials [283 Associated Clinical Trials listed on BioPortfolio]

Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers

The purpose of the study is to assess if the antimalarial drugs Dihydroartemisinine + Piperaquine (DP) are effective in preventing malaria infection for forest ranger

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1026 Associated Companies listed on BioPortfolio]

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive...

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products so...

Forest Laboratories, Inc. and Almirall, S.A.

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-esta...

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

Forest Laboratories, Inc. and Clinical Data, Inc.

Forest Laboratories’ (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well...

More Information about "Forest Laboratories, Inc." on BioPortfolio

We have published hundreds of Forest Laboratories, Inc. news stories on BioPortfolio along with dozens of Forest Laboratories, Inc. Clinical Trials and PubMed Articles about Forest Laboratories, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forest Laboratories, Inc. Companies in our database. You can also find out about relevant Forest Laboratories, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record